about
Assessment of Myocardial Fibrosis in Mice Using a T2*-Weighted 3D Radial Magnetic Resonance Imaging SequenceMyocardial fibrosis: biomedical research from bench to bedside.Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot studyDiffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational studyShould Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Not Routinely Be Treated With Coronary Artery Bypass GraftingCharacterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.MicroRNA signatures of resveratrol in the ischemic heart.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.Sepsis-induced cardiomyopathy.Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring.Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative StressPartition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumineIncreased stiffness is the major early abnormality in a pig model of severe aortic stenosis and predisposes to congestive heart failure in the absence of systolic dysfunction.Radiotherapy Induces Development of Fragmented QRS in Patients with Breast CancerT1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis.The protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonanceAre There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes.Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodellingMesenchymal Stem Cells Combined with Hepatocyte Growth Factor Therapy for Attenuating Ischaemic Myocardial Fibrosis: Assessment using Multimodal Molecular Imaging.Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral MyocarditisSubclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.MRI in acute myocardial infarction.Mechanisms of disease: hypertrophic cardiomyopathy.Intensive hemodialysis: normalizing the "unphysiology" of conventional hemodialysis?Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.Cardiac magnetic resonance imaging in children.Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.Effects of short-term levothyroxine therapy on myocardial injuries in patients with severe overt hypothyroidism: Evidence from a cardiac MRI Study.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.Left Ventricular Stiffness in Adolescents and Young Adults with Repaired Tetralogy of Fallot.Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.Fibrosis imaging: Current concepts and future directions.Pyridoxamine improves survival and limits cardiac dysfunction after MI.
P2860
Q27304522-55AB70CE-229C-4956-98D0-C11B43861C40Q30362840-965B0653-3B33-45D6-9F8A-4BED78BAFCB3Q30375735-FC9569A8-85CA-4FA0-803F-E61B93DF6BCDQ30408445-B0C6618A-2317-44CB-9826-F0173EF69337Q33894096-053F0561-DCFE-468B-BBAB-166A5FBF0078Q34432633-9FE3BD83-AB53-48D0-9865-E500C52CC538Q34484945-46112563-38D0-4F14-A36F-4F753057FD25Q34686600-BCAC7F19-4368-43F2-A8B3-F107E70B940CQ34846884-D49CAF12-E4C2-4D8C-B29D-570F7323107BQ35687065-E37F27F3-C833-4FFC-90B0-98BB855E4D23Q35723587-EC4CA0B4-B7DB-451D-9286-6D0EDCD3CBD8Q35953912-8AD66346-5261-4949-9F99-08FFC401BD2EQ36095116-A67570BD-6744-4E67-B739-61BB107D9BD5Q36141429-A89DE257-9733-449A-8ABE-A083533D7D3EQ36170686-9BF4FCF9-4C36-43BF-ACE6-2CA6CBACD494Q36178941-53B4E26D-F8CE-46F0-BBC8-25A17D7347E3Q36220925-B347F32A-AEA4-4600-B84D-2BA99110167AQ36406587-D16667EC-9F07-4A64-B59F-3EB9BDB3F059Q36422461-4A6A9308-32C8-4A28-9BE2-F33528617C35Q36583294-877962AB-C79B-4655-BED8-53DFF825D797Q37096257-24B25B20-6977-456E-B334-9D6E3155A705Q37386157-2F03E9B8-5F20-4BA8-8AB5-B62D35DF5BBCQ37448546-851D7889-5888-4B9D-B8FF-50C49CE63D8DQ37703469-17004B1A-73DB-4AE9-8894-338F0717DD93Q37717191-E804BE11-3548-43DB-81C3-15BDC6A4C18EQ37812993-D13190AB-0176-422F-A730-6191175245C8Q37949516-2A289B33-A800-40F7-8E49-692D03BC9439Q37961962-4B238CD6-E1DC-4317-B664-E39C9210B825Q38121064-898ACFE8-2290-4214-AD9D-AE5FA513F7C3Q38304855-18530CFD-B8E4-48E6-A482-136B7542BA01Q38374396-B7444BAE-3B1A-453E-896E-4DC7FE0D7E66Q38769836-C029E51C-E857-447B-897D-F8D9EE51992AQ38890676-A5D2D334-1102-4CEE-A9BE-F284AD685083Q40488679-C15D573D-510D-4A1C-B123-F83970050C74Q40963394-B2844F0A-009D-433A-97B1-83C1CAEC6855Q41019099-87740549-590D-40D2-909A-B7EAAA524781Q42268752-F912A3F0-DB61-4C07-8A1A-11BB0963DE20Q42630377-9DB3C1F9-EE7B-4E73-9192-CC05966081ACQ47376188-EDEF8362-AB50-4F42-AB12-1EB5D2A81E5FQ47426086-7C8013C5-485E-4B7E-AB08-CF3FE7FFBB5F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of nonischemic myocardial fibrosis.
@en
Assessment of nonischemic myocardial fibrosis.
@nl
type
label
Assessment of nonischemic myocardial fibrosis.
@en
Assessment of nonischemic myocardial fibrosis.
@nl
prefLabel
Assessment of nonischemic myocardial fibrosis.
@en
Assessment of nonischemic myocardial fibrosis.
@nl
P1476
Assessment of nonischemic myocardial fibrosis.
@en
P2093
Christine Jellis
Thomas H Marwick
P356
10.1016/J.JACC.2010.02.047
P407
P577
2010-07-01T00:00:00Z